董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Molly J. Coye Director 79 33.89万美元 未持股 2018-02-23
Jeffrey E. Garten Director 79 32.59万美元 未持股 2018-02-23
Ellen M. Hancock Director 82 34.84万美元 未持股 2018-02-23
Richard J. Harrington Director 79 31.93万美元 未持股 2018-02-23
Edward J. Ludwig Director 74 38.24万美元 未持股 2018-02-23
Joseph P. Newhouse Director 84 33.34万美元 未持股 2018-02-23
Mark T. Bertolini Chairman and Chief Executive Officer and Director 61 1866.23万美元 未持股 2018-02-23
Fernando Aguirre Director 68 29.58万美元 未持股 2018-02-23
Roger N. Farah Director 73 34.98万美元 未持股 2018-02-23
Betsy Cohen Director 84 33.46万美元 未持股 2018-02-23
Frank M. Clark, Jr. Director 80 33.19万美元 未持股 2018-02-23
Olympia J. Snowe Director 79 29.63万美元 未持股 2018-02-23

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Harold L. Paz Executive Vice President, Chief Medical Officer 63 未披露 未持股 2018-02-23
Karen S. Lynch President 55 732.75万美元 未持股 2018-02-23
Richard M. Jelinek Executive Vice President, Enterprise Strategy 52 未披露 未持股 2018-02-23
Margaret M. McCarthy Executive Vice President, Operations and Technology 64 426.46万美元 未持股 2018-02-23
Mark T. Bertolini Chairman and Chief Executive Officer and Director 61 1866.23万美元 未持股 2018-02-23
Thomas J. Sabatino, Jr. Executive Vice President and General Counsel 59 1098.85万美元 未持股 2018-02-23
Margaret M. McCarthy Executive Vice President, Operations and Technology 64 未披露 未持股 2018-02-23
Francis S. Soistman Executive Vice President, Government Services 61 521.98万美元 未持股 2018-02-23
Shawn M. Guertin Executive Vice President, Chief Financial Officer and Chief Enterprise Risk Officer 54 588.57万美元 未持股 2018-02-23

董事简历

中英对照 |  中文 |  英文
Molly J. Coye

Molly J. Coye于2010年9月在加州大学洛杉矶分校卫生系统全面医疗组织担任首席创新官。她在CalRHIO(加州非盈利健康信息交换组织)蛋总总裁和首席执行官,并在卫生技术中心(非盈利教育和研究机构)担任首席执行官,卫生技术中心由她于2000年12月创办。她于2010年1月在公共卫生学院担任高级顾问。在此之前,自1997年至2000年12月期间内她在列文集团西海岸办事处(咨询)的公共私营部门工作;自1996年至1997年期间内她在健康德始克公司担任执行副总统兼策略发展官;自1993年至1996年期间内她在古德撒马利亚卫生医院临床操作部担任高级副总裁;自1991年至1993年期间内她在加州卫生服务部门担任主管;自1990年至 1991年期间内她在公共卫生部门、卫生政策与管理部门以及约翰霍普金斯大学公共卫生学院担任管理人;自1986年至1989年期间内他在新泽西州健康部门担任委员;自1985年至1986年期间内她在新泽西州健康和环境办事处担任特别顾问;自1980年至1985年期间内她在国家职业安全与健康研究所医学担任调查官。她曾在PATH(非营利组织发展中国际卫生技术)担任董事长,并在Prosetta公司(生物技术开发化验和治疗公司)董事会任职。她也曾在安泰基金会公司担任董事。


Molly J. Coye is Social Entrepreneur in Residence for the Network for Excellence in Healthcare Innovation, a non-profit, non-partisan health policy institute focused on enabling innovations that improve the quality and lower the costs of health care, a position she assumed in June 2015. Previously, Dr. Coye served as Chief Innovation Officer of the UCLA Health System comprehensive health care organization, from September 2010 to May 2015. She also served as President and Chief Executive Officer of CalRHIO (non-profit California health information exchange organization) and Chief Executive Officer of the Health Technology Center (non-profit education and research organization), which she founded in December 2000. She also served as a Senior Advisor to the Public Health Institute until August 2010. Earlier, Dr. Coye served in both the public and private sectors as Senior Vice President of the West Coast Office of The Lewin Group (consulting) from 1997 to December 2000; Executive Vice President, Strategic Development, of HealthDesk Corporation from 1996 to 1997; Senior Vice President, Clinical Operations, Good Samaritan Health Hospital from 1993 to 1996; Director of the California Department of Health Services from 1991 to 1993; Head of the Division of Public Health, Department of Health Policy and Management, Johns Hopkins School of Hygiene and Public Health from 1990 to 1991; Commissioner of Health of the New Jersey State Department of Health from 1986 to 1989; Special Advisor for Health and the Environment, State of New Jersey Office of the Governor from 1985 to 1986; and National Institute for Occupational Safety and Health Medical Investigative Officer from 1980 to 1985. She formerly served as chair of PATH (non-profit organization developing technologies for international health) and Big White Wall, Ltd. (online behavioral health company providing a platform and services). Dr. Coye currently serves as chair of the board of directors of Prosetta Biosciences, Inc. (biotechnology firm developing assays and therapeutics).
Molly J. Coye于2010年9月在加州大学洛杉矶分校卫生系统全面医疗组织担任首席创新官。她在CalRHIO(加州非盈利健康信息交换组织)蛋总总裁和首席执行官,并在卫生技术中心(非盈利教育和研究机构)担任首席执行官,卫生技术中心由她于2000年12月创办。她于2010年1月在公共卫生学院担任高级顾问。在此之前,自1997年至2000年12月期间内她在列文集团西海岸办事处(咨询)的公共私营部门工作;自1996年至1997年期间内她在健康德始克公司担任执行副总统兼策略发展官;自1993年至1996年期间内她在古德撒马利亚卫生医院临床操作部担任高级副总裁;自1991年至1993年期间内她在加州卫生服务部门担任主管;自1990年至 1991年期间内她在公共卫生部门、卫生政策与管理部门以及约翰霍普金斯大学公共卫生学院担任管理人;自1986年至1989年期间内他在新泽西州健康部门担任委员;自1985年至1986年期间内她在新泽西州健康和环境办事处担任特别顾问;自1980年至1985年期间内她在国家职业安全与健康研究所医学担任调查官。她曾在PATH(非营利组织发展中国际卫生技术)担任董事长,并在Prosetta公司(生物技术开发化验和治疗公司)董事会任职。她也曾在安泰基金会公司担任董事。
Molly J. Coye is Social Entrepreneur in Residence for the Network for Excellence in Healthcare Innovation, a non-profit, non-partisan health policy institute focused on enabling innovations that improve the quality and lower the costs of health care, a position she assumed in June 2015. Previously, Dr. Coye served as Chief Innovation Officer of the UCLA Health System comprehensive health care organization, from September 2010 to May 2015. She also served as President and Chief Executive Officer of CalRHIO (non-profit California health information exchange organization) and Chief Executive Officer of the Health Technology Center (non-profit education and research organization), which she founded in December 2000. She also served as a Senior Advisor to the Public Health Institute until August 2010. Earlier, Dr. Coye served in both the public and private sectors as Senior Vice President of the West Coast Office of The Lewin Group (consulting) from 1997 to December 2000; Executive Vice President, Strategic Development, of HealthDesk Corporation from 1996 to 1997; Senior Vice President, Clinical Operations, Good Samaritan Health Hospital from 1993 to 1996; Director of the California Department of Health Services from 1991 to 1993; Head of the Division of Public Health, Department of Health Policy and Management, Johns Hopkins School of Hygiene and Public Health from 1990 to 1991; Commissioner of Health of the New Jersey State Department of Health from 1986 to 1989; Special Advisor for Health and the Environment, State of New Jersey Office of the Governor from 1985 to 1986; and National Institute for Occupational Safety and Health Medical Investigative Officer from 1980 to 1985. She formerly served as chair of PATH (non-profit organization developing technologies for international health) and Big White Wall, Ltd. (online behavioral health company providing a platform and services). Dr. Coye currently serves as chair of the board of directors of Prosetta Biosciences, Inc. (biotechnology firm developing assays and therapeutics).
Jeffrey E. Garten

Jeffrey E. Garten于2005年7月1日在耶鲁大学国际贸易实务、金融和商业系担任Juan Trippe荣誉教授,他于1995年开始担任耶鲁管理学院院长。他于2005年10月在Garten Rothkopf全球咨询公司担任董事长职务,自1973年至1979年期间内他在美国国务院白宫担任高级职务。他于1979年加入雷曼兄弟公司(投资银行),自1984年至1987年开始担任总经理。他于1987年创办了艾略特集团公司(投资银行),并担任总裁直至1990年为止,同时他也是百仕通集团的总经理(私人商业银行)。自1992年至1993年期间内他在哥伦比亚大学商学院担任经济金融学教授。他于1995年被任命为美国国际贸易商务部副部长。他是以下书籍的作者:《寒冷的和平》,这本书主要讲的是美国、日本、德国与霸权主义的斗争;《大十联盟》:新兴市场将如何改变我们的生活;《首席执行官的思想》;以及《政治财富》,这本书主要讲一个新的议程商界领袖。他是国际救援委员会的受托人以及安泰基金会的主管。他在标准普尔公司董事会任职,标准普尔公司是麦格劳-希尔公司的一个部门。


Jeffrey E. Garten is Dean Emeritus of the Yale School of Management. Previously, he served as Yale University’s Juan Trippe Professor in the Practice of International Trade, Finance and Business from 2005 to 2015. From 1995 to 2005 he served as Dean of the Yale School of Management. Mr. Garten also served as Chairman of Garten Rothkopf global consulting firm, from 2005 to 2016. Earlier, Mr. Garten held senior posts on the White House staff and at the U.S. Department of State from 1973 to 1979. He joined Shearson Lehman Brothers (investment banking) in 1979 and served as Managing Director from 1984 to 1987. In 1987 Mr. Garten founded Eliot Group, Inc. (investment banking) and served as President until 1990 when he became Managing Director of The Blackstone Group (private merchant bank). From 1992 to 1993 Mr. Garten was Professor of Finance and Economics at Columbia University’s Graduate School of Business. He was appointed U.S. Under Secretary of Commerce for International Trade in 1993 and served in that position until 1995. He is the author of A Cold Peace: America, Japan, Germany and the Struggle for Supremacy; The Big Ten: Big Emerging Markets and How They Will Change Our Lives; The Mind of the CEO; The Politics of Fortune: A New Agenda for Business Leaders; and From Silk to Silicon: The Story of Globalization Through Ten Extraordinary Lives. Mr. Garten is a trustee of the International Rescue Committee.
Jeffrey E. Garten于2005年7月1日在耶鲁大学国际贸易实务、金融和商业系担任Juan Trippe荣誉教授,他于1995年开始担任耶鲁管理学院院长。他于2005年10月在Garten Rothkopf全球咨询公司担任董事长职务,自1973年至1979年期间内他在美国国务院白宫担任高级职务。他于1979年加入雷曼兄弟公司(投资银行),自1984年至1987年开始担任总经理。他于1987年创办了艾略特集团公司(投资银行),并担任总裁直至1990年为止,同时他也是百仕通集团的总经理(私人商业银行)。自1992年至1993年期间内他在哥伦比亚大学商学院担任经济金融学教授。他于1995年被任命为美国国际贸易商务部副部长。他是以下书籍的作者:《寒冷的和平》,这本书主要讲的是美国、日本、德国与霸权主义的斗争;《大十联盟》:新兴市场将如何改变我们的生活;《首席执行官的思想》;以及《政治财富》,这本书主要讲一个新的议程商界领袖。他是国际救援委员会的受托人以及安泰基金会的主管。他在标准普尔公司董事会任职,标准普尔公司是麦格劳-希尔公司的一个部门。
Jeffrey E. Garten is Dean Emeritus of the Yale School of Management. Previously, he served as Yale University’s Juan Trippe Professor in the Practice of International Trade, Finance and Business from 2005 to 2015. From 1995 to 2005 he served as Dean of the Yale School of Management. Mr. Garten also served as Chairman of Garten Rothkopf global consulting firm, from 2005 to 2016. Earlier, Mr. Garten held senior posts on the White House staff and at the U.S. Department of State from 1973 to 1979. He joined Shearson Lehman Brothers (investment banking) in 1979 and served as Managing Director from 1984 to 1987. In 1987 Mr. Garten founded Eliot Group, Inc. (investment banking) and served as President until 1990 when he became Managing Director of The Blackstone Group (private merchant bank). From 1992 to 1993 Mr. Garten was Professor of Finance and Economics at Columbia University’s Graduate School of Business. He was appointed U.S. Under Secretary of Commerce for International Trade in 1993 and served in that position until 1995. He is the author of A Cold Peace: America, Japan, Germany and the Struggle for Supremacy; The Big Ten: Big Emerging Markets and How They Will Change Our Lives; The Mind of the CEO; The Politics of Fortune: A New Agenda for Business Leaders; and From Silk to Silicon: The Story of Globalization Through Ten Extraordinary Lives. Mr. Garten is a trustee of the International Rescue Committee.
Ellen M. Hancock

Ellen M. Hancock自2005年至2007年期间在Jazz科技公司担任总裁,以及在Jazz科技公司的前身Acquicor技术公司担任总裁和首席营运官。Acquicor技术公司于2007年2月与Jazz半导体公司合并之后改名为Jazz科技公司。Acquicor技术公司是以收购技术、多媒体和网络领域企业为目的的收购公司。她曾在艾克赛达斯通信公司(网络系统和网络管理服务)担任董事会主席兼首席执行官。她于1998年3月加入艾克赛达斯通信公司,自2000年6月至2001年9月期间内担任董事长,自1998年9月至2001年9月期间内担任首席执行官,自1998年3月至2000年6月期间内担任总裁。自1996年至1995年期间内她在商业机器公司(商业处理系统,装备服务公司)出任过许多职务,包括管理和行政职务。她于1985年在美国国际商用机器公司担任副总裁职务,并于1986年至1988年期间内在通讯产品部门担任总裁,同时她也是网络系统的总经理。她于1992年被选为美国国际商用机器公司的高级副总裁,并于1993年被任命为高级副总裁兼集团执行人,直到1995年为止。自1995年9月至1996年5月她在美国国家半导体公司担任执行副总裁兼首席运营官,并于1996年7月至1997年7月期间在苹果电脑公司(私人电脑)担任研究和开发和首席技术官兼执行副总裁。自2004年2月至2008年8月期间内他在电子资讯系统有限公司担任公司董事。


Ellen M. Hancock served as the President of Jazz Technologies, Inc. and President and Chief Operating Officer of its predecessor, Acquicor Technology Inc., from August 2005 to June 2007. Prior to its merger with Jazz Semiconductor, Inc., a wafer foundry, in February 2007 Jazz Technologies then known as Acquicor was a blank check company formed for the purpose of acquiring businesses in the technology, multimedia and networking sector. Mrs. Hancock previously served as Chairman of the Board and Chief Executive Officer of Exodus Communications, Inc. (Internet system and network management services). She joined Exodus in March 1998 and served as Chairman from June 2000 to September 2001 Chief Executive Officer from September 1998 to September 2001 and President from March 1998 to June 2000. Mrs. Hancock held various staff, managerial and executive positions at International Business Machines Corporation (information-handling systems, equipment and services) from 1966 to 1995. She became a Vice President of IBM in 1985 and served as President, Communication Products Division, from 1986 to 1988 when she was named General Manager, Networking Systems. Mrs. Hancock was elected an IBM Senior Vice President in November 1992 and in 1993 was appointed Senior Vice President and Group Executive, which position she held until February 1995. Mrs. Hancock served as an Executive Vice President and Chief Operating Officer of National Semiconductor Corporation (semiconductors) from September 1995 to May 1996 and served as Executive Vice President for Research and Development and Chief Technology Officer of Apple Computer, Inc. (personal computers) from July 1996 to July 1997.
Ellen M. Hancock自2005年至2007年期间在Jazz科技公司担任总裁,以及在Jazz科技公司的前身Acquicor技术公司担任总裁和首席营运官。Acquicor技术公司于2007年2月与Jazz半导体公司合并之后改名为Jazz科技公司。Acquicor技术公司是以收购技术、多媒体和网络领域企业为目的的收购公司。她曾在艾克赛达斯通信公司(网络系统和网络管理服务)担任董事会主席兼首席执行官。她于1998年3月加入艾克赛达斯通信公司,自2000年6月至2001年9月期间内担任董事长,自1998年9月至2001年9月期间内担任首席执行官,自1998年3月至2000年6月期间内担任总裁。自1996年至1995年期间内她在商业机器公司(商业处理系统,装备服务公司)出任过许多职务,包括管理和行政职务。她于1985年在美国国际商用机器公司担任副总裁职务,并于1986年至1988年期间内在通讯产品部门担任总裁,同时她也是网络系统的总经理。她于1992年被选为美国国际商用机器公司的高级副总裁,并于1993年被任命为高级副总裁兼集团执行人,直到1995年为止。自1995年9月至1996年5月她在美国国家半导体公司担任执行副总裁兼首席运营官,并于1996年7月至1997年7月期间在苹果电脑公司(私人电脑)担任研究和开发和首席技术官兼执行副总裁。自2004年2月至2008年8月期间内他在电子资讯系统有限公司担任公司董事。
Ellen M. Hancock served as the President of Jazz Technologies, Inc. and President and Chief Operating Officer of its predecessor, Acquicor Technology Inc., from August 2005 to June 2007. Prior to its merger with Jazz Semiconductor, Inc., a wafer foundry, in February 2007 Jazz Technologies then known as Acquicor was a blank check company formed for the purpose of acquiring businesses in the technology, multimedia and networking sector. Mrs. Hancock previously served as Chairman of the Board and Chief Executive Officer of Exodus Communications, Inc. (Internet system and network management services). She joined Exodus in March 1998 and served as Chairman from June 2000 to September 2001 Chief Executive Officer from September 1998 to September 2001 and President from March 1998 to June 2000. Mrs. Hancock held various staff, managerial and executive positions at International Business Machines Corporation (information-handling systems, equipment and services) from 1966 to 1995. She became a Vice President of IBM in 1985 and served as President, Communication Products Division, from 1986 to 1988 when she was named General Manager, Networking Systems. Mrs. Hancock was elected an IBM Senior Vice President in November 1992 and in 1993 was appointed Senior Vice President and Group Executive, which position she held until February 1995. Mrs. Hancock served as an Executive Vice President and Chief Operating Officer of National Semiconductor Corporation (semiconductors) from September 1995 to May 1996 and served as Executive Vice President for Research and Development and Chief Technology Officer of Apple Computer, Inc. (personal computers) from July 1996 to July 1997.
Richard J. Harrington

Richard J. Harrington于2008年4月在汤姆森业务技术公司和综合信息解决公司(被路透集团收购之前)担任总裁兼首席执行官。自2008年4月至2009年10月期间内他在汤森路透基金会担任董事会主席。他现今在白色球集团(风险投资公司)担任董事长。他于1982年在汤姆逊公司出任了许多高级领导型职务,其中包括汤姆森报社、汤姆森专业出版社的首席执行官。他于1972年在亚瑟扬公司(会计师事务所)任职,从此开始了他的职业生涯,他在亚瑟扬公司(会计师事务所)是一名挂牌正式会计师。他于2002年在罗德岛大学担任荣誉法学博士。他于2007年获得耶鲁大学首席执行官领导学院颁发的领导者奖;他获得了执行委员会首席执行官年度奖;他还凭借参与大量的慈善活动获得了国家执行委员会的人文年度奖。


Richard J. Harrington is Chairman and General Partner of The Cue Ball Group a venture capital firm. Previously, he served as President and Chief Executive Officer of The Thomson Corporation (business technology and integrated information solutions) prior to its acquisition of Reuters Group PLC in April 2008. From April 2008 to October 2009 he served as Chairman of the Thomson Reuters Foundation. Mr. Harrington held a number of senior leadership positions within Thomson since 1982 including CEO of Thomson Newspapers, and CEO of Thomson Professional Publishing. Mr. Harrington began his professional career with Arthur Young & Co. (public accounting firm) in 1972 where he became a licensed certified public accountant. In 2002 he was presented an Honorary Doctorate of Laws from University of Rhode Island. In 2007 he received the "Legend in Leadership" award from the Yale University Chief Executive Leadership Institute; the "CEO of the Year" award from the Executive Council; and the "Man of the Year" award from the National Executive Council for his many philanthropic activities.
Richard J. Harrington于2008年4月在汤姆森业务技术公司和综合信息解决公司(被路透集团收购之前)担任总裁兼首席执行官。自2008年4月至2009年10月期间内他在汤森路透基金会担任董事会主席。他现今在白色球集团(风险投资公司)担任董事长。他于1982年在汤姆逊公司出任了许多高级领导型职务,其中包括汤姆森报社、汤姆森专业出版社的首席执行官。他于1972年在亚瑟扬公司(会计师事务所)任职,从此开始了他的职业生涯,他在亚瑟扬公司(会计师事务所)是一名挂牌正式会计师。他于2002年在罗德岛大学担任荣誉法学博士。他于2007年获得耶鲁大学首席执行官领导学院颁发的领导者奖;他获得了执行委员会首席执行官年度奖;他还凭借参与大量的慈善活动获得了国家执行委员会的人文年度奖。
Richard J. Harrington is Chairman and General Partner of The Cue Ball Group a venture capital firm. Previously, he served as President and Chief Executive Officer of The Thomson Corporation (business technology and integrated information solutions) prior to its acquisition of Reuters Group PLC in April 2008. From April 2008 to October 2009 he served as Chairman of the Thomson Reuters Foundation. Mr. Harrington held a number of senior leadership positions within Thomson since 1982 including CEO of Thomson Newspapers, and CEO of Thomson Professional Publishing. Mr. Harrington began his professional career with Arthur Young & Co. (public accounting firm) in 1972 where he became a licensed certified public accountant. In 2002 he was presented an Honorary Doctorate of Laws from University of Rhode Island. In 2007 he received the "Legend in Leadership" award from the Yale University Chief Executive Leadership Institute; the "CEO of the Year" award from the Executive Council; and the "Man of the Year" award from the National Executive Council for his many philanthropic activities.
Edward J. Ludwig

Edward J. Ludwig于2011年10月31日进入公司董事会。他于2012年7月在贝克顿公司、迪金森公司和BD公司担任董事长职务。他于1979年加入BD 公司,自2000年1月至2011年9月期间内他担任首席执行官、总裁、财务总监以及其他职务。再加入BD公司之前,他在永道会计师事务所(现在被称为普华永道律师事务所)担任高级审计师,在此期间内,他获得了注册会计师资格证。并且在基德公司担任财务与策略分析师。他在安泰保险公司董事会担任首席董事,并在财务委员会董事会担任主席。他也在波士顿科学公司董事会任职。他在哈肯萨克大学医学中心网络董事会担任副董事长,他是战略咨询委员会资金使用费部门的一员并在POCARED公司担任主管。他是更高职员领导中心董事会成员之一。他任职于哥伦比亚商学院监督委员会。他在美国先进医疗技术协会担任董事会主席,美国先进医疗技术协会是世界上最大的医疗技术协会。他在约翰霍普金斯彭博公共卫生学院健康咨询委员会担任主席。他拥有圣十字学院的金融会计学士学位以及哥伦比亚大学的金融工商管理学硕士学位。


Edward J. Ludwig is the former Chairman of the Board of Becton, Dickinson and Company (BDX), a global medical technology company, having served in that position from February 2002 through June 2012. He also served as BDX's Chief Executive Officer from January 2000 to September 2011 and as its President from May 1999 to December 2008. Mr. Ludwig joined BDX as a senior financial analyst in 1979. Prior to joining BDX, Mr. Ludwig served as a senior auditor with Coopers and Lybrand (now PricewaterhoeCoopers), where he earned his CPA, and as a financial and strategic analyst at Kidde, Inc. Mr. Ludwig was a member of the board of directors of POCARED Diagnostics Ltd, a privately held company foced on infectio disease diagnostics from 2013 to 2022. He formerly served as a director of CVS Health Corporation, Aetna, Inc., Xylem, Inc. and as Vice Chair of the board of trtees of the Hackensack University Medical Center Network. He is currently the Chairman of the Board of GRIP Molecular, a startup primary care diagnostic company. Mr. Ludwig received an MBA from Columbia University and a BA in economics and accounting from The College of Holy Cross.
Edward J. Ludwig于2011年10月31日进入公司董事会。他于2012年7月在贝克顿公司、迪金森公司和BD公司担任董事长职务。他于1979年加入BD 公司,自2000年1月至2011年9月期间内他担任首席执行官、总裁、财务总监以及其他职务。再加入BD公司之前,他在永道会计师事务所(现在被称为普华永道律师事务所)担任高级审计师,在此期间内,他获得了注册会计师资格证。并且在基德公司担任财务与策略分析师。他在安泰保险公司董事会担任首席董事,并在财务委员会董事会担任主席。他也在波士顿科学公司董事会任职。他在哈肯萨克大学医学中心网络董事会担任副董事长,他是战略咨询委员会资金使用费部门的一员并在POCARED公司担任主管。他是更高职员领导中心董事会成员之一。他任职于哥伦比亚商学院监督委员会。他在美国先进医疗技术协会担任董事会主席,美国先进医疗技术协会是世界上最大的医疗技术协会。他在约翰霍普金斯彭博公共卫生学院健康咨询委员会担任主席。他拥有圣十字学院的金融会计学士学位以及哥伦比亚大学的金融工商管理学硕士学位。
Edward J. Ludwig is the former Chairman of the Board of Becton, Dickinson and Company (BDX), a global medical technology company, having served in that position from February 2002 through June 2012. He also served as BDX's Chief Executive Officer from January 2000 to September 2011 and as its President from May 1999 to December 2008. Mr. Ludwig joined BDX as a senior financial analyst in 1979. Prior to joining BDX, Mr. Ludwig served as a senior auditor with Coopers and Lybrand (now PricewaterhoeCoopers), where he earned his CPA, and as a financial and strategic analyst at Kidde, Inc. Mr. Ludwig was a member of the board of directors of POCARED Diagnostics Ltd, a privately held company foced on infectio disease diagnostics from 2013 to 2022. He formerly served as a director of CVS Health Corporation, Aetna, Inc., Xylem, Inc. and as Vice Chair of the board of trtees of the Hackensack University Medical Center Network. He is currently the Chairman of the Board of GRIP Molecular, a startup primary care diagnostic company. Mr. Ludwig received an MBA from Columbia University and a BA in economics and accounting from The College of Holy Cross.
Joseph P. Newhouse

Joseph P. Newhouse于1988年在美国哈佛大学卫生政策与管理担任John D. MacArthur荣誉教授。他在哈佛大学卫生政策研究教育部门担任主管,他还在卫生政策深造委员会担任主席,同时他也是哈佛医学院肯尼迪政府学院、哈佛大学公共卫生文学院和科学学院教学员之一。在加入哈佛大学之前,自1968年至1988年他在兰德公司出任了许多职务,自1972年至1988年期间内他在兰德研究生院成为教员之一,自1971年至1988年期间内在健康科学研究项目担任副经理。自1972年至1981年期间内他在高级经济学家组织任职,自1981年至1985年之间在经济学系担任系长,自1985年至1988年期间内成为企业高级研究员。他在《卫生经济学杂志》担任主编,任职30年。他在国家经济研究局担任研究助理,并在美国国家科学院医学研究所、《新英格兰医学杂志》编辑委员会、美国科学院以及国家质量保证委员会任职。他还撰写了以下著作:《医疗难题》主要讲述了兰德医疗保险实验。他也在安泰基金会担任董事。


Joseph P. Newhouse is the John D. MacArthur Professor of Health Policy and Management at Harvard University, a position he assumed in 1988. At Harvard, he also is the Director of the Division of Health Policy Research and Education, the Director of the Interfaculty Initiative on Health Policy, and a member of the faculties of the John F. Kennedy School of Government, the Harvard Medical School, the Harvard School of Public Health and the Faculty of Arts and Sciences. Prior to joining Harvard, Dr. Newhouse held various positions at The RAND Corporation from 1968 to 1988 serving as a faculty member of the RAND Graduate School from 1972 to 1988 as Deputy Program Manager for Health Sciences Research from 1971 to 1988 Senior Staff Economist from 1972 to 1981 Head of the Economics Department from 1981 to 1985 and as a Senior Corporate Fellow from 1985 to 1988. Dr. Newhouse was the Founding Editor of the Journal of Health Economics, which he edited for 30 years. He is a Faculty Research Associate of the National Bureau of Economic Research, a member of the National Academy of Medicine, a fellow of the American Academy of Arts and Sciences, and a director of the National Committee for Quality Assurance. Dr. Newhouse is a former member of the New England Journal of Medicine Editorial Board and the author of Free for All: Lessons from the RAND Health Insurance Experiment and Pricing the Priceless: A Health Care Conundrum.
Joseph P. Newhouse于1988年在美国哈佛大学卫生政策与管理担任John D. MacArthur荣誉教授。他在哈佛大学卫生政策研究教育部门担任主管,他还在卫生政策深造委员会担任主席,同时他也是哈佛医学院肯尼迪政府学院、哈佛大学公共卫生文学院和科学学院教学员之一。在加入哈佛大学之前,自1968年至1988年他在兰德公司出任了许多职务,自1972年至1988年期间内他在兰德研究生院成为教员之一,自1971年至1988年期间内在健康科学研究项目担任副经理。自1972年至1981年期间内他在高级经济学家组织任职,自1981年至1985年之间在经济学系担任系长,自1985年至1988年期间内成为企业高级研究员。他在《卫生经济学杂志》担任主编,任职30年。他在国家经济研究局担任研究助理,并在美国国家科学院医学研究所、《新英格兰医学杂志》编辑委员会、美国科学院以及国家质量保证委员会任职。他还撰写了以下著作:《医疗难题》主要讲述了兰德医疗保险实验。他也在安泰基金会担任董事。
Joseph P. Newhouse is the John D. MacArthur Professor of Health Policy and Management at Harvard University, a position he assumed in 1988. At Harvard, he also is the Director of the Division of Health Policy Research and Education, the Director of the Interfaculty Initiative on Health Policy, and a member of the faculties of the John F. Kennedy School of Government, the Harvard Medical School, the Harvard School of Public Health and the Faculty of Arts and Sciences. Prior to joining Harvard, Dr. Newhouse held various positions at The RAND Corporation from 1968 to 1988 serving as a faculty member of the RAND Graduate School from 1972 to 1988 as Deputy Program Manager for Health Sciences Research from 1971 to 1988 Senior Staff Economist from 1972 to 1981 Head of the Economics Department from 1981 to 1985 and as a Senior Corporate Fellow from 1985 to 1988. Dr. Newhouse was the Founding Editor of the Journal of Health Economics, which he edited for 30 years. He is a Faculty Research Associate of the National Bureau of Economic Research, a member of the National Academy of Medicine, a fellow of the American Academy of Arts and Sciences, and a director of the National Committee for Quality Assurance. Dr. Newhouse is a former member of the New England Journal of Medicine Editorial Board and the author of Free for All: Lessons from the RAND Health Insurance Experiment and Pricing the Priceless: A Health Care Conundrum.
Mark T. Bertolini

Mark T. Bertolini在安泰保险公司担任董事会主席、首席执行官兼总裁。他于2011年4月8日担任董事会主席职务,于2010年11月29日担任首席执行官职务。他于2003年加入安泰保险公司并成为安泰专业产品制造负责人。他于2007年7月被任命为总裁,并负责处理涵盖安泰企业业务范围的广泛医疗保健产品和相关服务的事务。在成为安泰公司的总裁之前,他担任执行副总裁兼管理人,负责安泰公司的地区业务,其中包括公司的在职人员、退休人员、项目小组和中间市场业务,还包括众多产品、网络和服务区域业务。在加入安泰公司之前,他在信诺保险集团、NYLCare健康计划公司与SelectCare公司担任首席职位,他在这些公司担任总裁兼首席执行官,他还在墙洞帮儿童营和Fidelco导盲犬协会担任董事,墙洞帮儿童营是一个由保罗-纽曼创办的组织,这个组织专门帮助患有癌症或其他严重疾病的儿童。Fidelco导盲犬协会是一个繁殖,训练和接收德国牧羊犬导盲犬以帮助失明人士的组织。


Mark T. Bertolini,currently serving as the Chief Executive Officer of Oscar Health, Inc., a health insurance company that leverages a full-stack technology platform, a position he has held since 2023.Before taking on the role at Oscar Health, Mark was the Co-Chief Executive Officer of Bridgewater Associates, LP, a prominent global investment management firm, from 2022 to 2023. His extensive career in the healthcare industry includes significant leadership roles at Aetna Inc., a Fortune 100 diversified healthcare benefits company, where he served as Chairman from 2011 to 2018, Chief Executive Officer from 2010 to 2018, and President from 2007 to 2010. Prior to these roles, he held various executive positions at Aetna from 2003 to 2007.Mark's career began in the healthcare sector, where he held executive positions at companies such as Cigna, NYLCare Health Plans, and SelectCare, Inc. from 1985 to 2003.
Mark T. Bertolini在安泰保险公司担任董事会主席、首席执行官兼总裁。他于2011年4月8日担任董事会主席职务,于2010年11月29日担任首席执行官职务。他于2003年加入安泰保险公司并成为安泰专业产品制造负责人。他于2007年7月被任命为总裁,并负责处理涵盖安泰企业业务范围的广泛医疗保健产品和相关服务的事务。在成为安泰公司的总裁之前,他担任执行副总裁兼管理人,负责安泰公司的地区业务,其中包括公司的在职人员、退休人员、项目小组和中间市场业务,还包括众多产品、网络和服务区域业务。在加入安泰公司之前,他在信诺保险集团、NYLCare健康计划公司与SelectCare公司担任首席职位,他在这些公司担任总裁兼首席执行官,他还在墙洞帮儿童营和Fidelco导盲犬协会担任董事,墙洞帮儿童营是一个由保罗-纽曼创办的组织,这个组织专门帮助患有癌症或其他严重疾病的儿童。Fidelco导盲犬协会是一个繁殖,训练和接收德国牧羊犬导盲犬以帮助失明人士的组织。
Mark T. Bertolini,currently serving as the Chief Executive Officer of Oscar Health, Inc., a health insurance company that leverages a full-stack technology platform, a position he has held since 2023.Before taking on the role at Oscar Health, Mark was the Co-Chief Executive Officer of Bridgewater Associates, LP, a prominent global investment management firm, from 2022 to 2023. His extensive career in the healthcare industry includes significant leadership roles at Aetna Inc., a Fortune 100 diversified healthcare benefits company, where he served as Chairman from 2011 to 2018, Chief Executive Officer from 2010 to 2018, and President from 2007 to 2010. Prior to these roles, he held various executive positions at Aetna from 2003 to 2007.Mark's career began in the healthcare sector, where he held executive positions at companies such as Cigna, NYLCare Health Plans, and SelectCare, Inc. from 1985 to 2003.
Fernando Aguirre

Fernando Aguirre,自2019年7月起担任董事。2004年1月至2012年10月,他担任Chiquita Brands International, Inc.的总裁兼首席执行官;2004年5月至2012年10月,他担任董事长。在此之前,他从1980年到2004年在宝洁公司担任各种全球营销和管理职务。他目前是CVS Health(一家上市的美国医疗保健公司,拥有CVS Pharmacy、CVS Caremark和Aetna)的董事会成员;百乐嘉利宝是一家上市公司,是世界上最大的可可加工商和巧克力制造商之一。他曾任职于其他董事会,包括Aetna, Inc., Coca-Cola Enterprises和Levi Strauss & Co.。Aguirre先生目前是Erie seawwolves Minor League棒球队(底特律老虎队的双AA附属球队)的所有者和首席执行官。他还拥有默特尔比奇鹈鹕队(Myrtle Beach Pelicans)的少数股权,这是芝加哥小熊队(Chicago Cubs)的低a级球队。Aguirre先生是墨西哥人,是西班牙裔社区的杰出人物,被西班牙裔商业杂志评为100位影响力人物之一,并被NFL授予西班牙裔传统领导奖。他持有Southern Illinois University Edwardsville的学士学位。


Fernando Aguirre,served as Chairman, President and CEO of Chiquita Brands International (2004-2012) after a 23-year career at Procter & Gamble where he held leadership roles including President of P&G Mexico and VP of global snacks. He currently serves on the boards of CVS Health (since 2018), Barry Callebaut AG, and Synchrony Financial. Aguirre holds a BS from Southern Illinois University Edwardsville.
Fernando Aguirre,自2019年7月起担任董事。2004年1月至2012年10月,他担任Chiquita Brands International, Inc.的总裁兼首席执行官;2004年5月至2012年10月,他担任董事长。在此之前,他从1980年到2004年在宝洁公司担任各种全球营销和管理职务。他目前是CVS Health(一家上市的美国医疗保健公司,拥有CVS Pharmacy、CVS Caremark和Aetna)的董事会成员;百乐嘉利宝是一家上市公司,是世界上最大的可可加工商和巧克力制造商之一。他曾任职于其他董事会,包括Aetna, Inc., Coca-Cola Enterprises和Levi Strauss & Co.。Aguirre先生目前是Erie seawwolves Minor League棒球队(底特律老虎队的双AA附属球队)的所有者和首席执行官。他还拥有默特尔比奇鹈鹕队(Myrtle Beach Pelicans)的少数股权,这是芝加哥小熊队(Chicago Cubs)的低a级球队。Aguirre先生是墨西哥人,是西班牙裔社区的杰出人物,被西班牙裔商业杂志评为100位影响力人物之一,并被NFL授予西班牙裔传统领导奖。他持有Southern Illinois University Edwardsville的学士学位。
Fernando Aguirre,served as Chairman, President and CEO of Chiquita Brands International (2004-2012) after a 23-year career at Procter & Gamble where he held leadership roles including President of P&G Mexico and VP of global snacks. He currently serves on the boards of CVS Health (since 2018), Barry Callebaut AG, and Synchrony Financial. Aguirre holds a BS from Southern Illinois University Edwardsville.
Roger N. Farah

Roger N. Farah,自2024年10月起担任Cvs Health Corporation董事会执行主席;自2022年5月起担任Cvs Health Corporation董事会主席;自2018年11月起担任Cvs Health Corporation的董事;2007年6月至2018年11月担任Aetna, Inc.的董事。他目前还担任The Progressive Corporation(一家汽车保险公司)的董事,并曾担任Tiffany & Co.的董事会主席和董事(直到2021年1月),以及Metro Bank PLC的董事(直到2020年3月)。


Roger N. Farah previoly served in executive officer positions at Ralph Lauren Corporation and Tory Burch LLC, an executive director at Tory Burch, and as a director at other public companies, primarily in the retail and health insurance indtries. The extensive management and operational experience Mr. Farah has obtained through over 40 years in the retail indtry enables him to provide insights, particularly in the areas of ctomer trends, product development, brand management, and risk analysis, from a consumer foced indtry that is different than the property and casualty insurance indtry. Due to his current and past service as a director of other public companies, he also has significant experience addressing the risks and corporate governance issues facing public companies, including serving as a member of their executive, compensation, governance, and corporate social responsibility committees.
Roger N. Farah,自2024年10月起担任Cvs Health Corporation董事会执行主席;自2022年5月起担任Cvs Health Corporation董事会主席;自2018年11月起担任Cvs Health Corporation的董事;2007年6月至2018年11月担任Aetna, Inc.的董事。他目前还担任The Progressive Corporation(一家汽车保险公司)的董事,并曾担任Tiffany & Co.的董事会主席和董事(直到2021年1月),以及Metro Bank PLC的董事(直到2020年3月)。
Roger N. Farah previoly served in executive officer positions at Ralph Lauren Corporation and Tory Burch LLC, an executive director at Tory Burch, and as a director at other public companies, primarily in the retail and health insurance indtries. The extensive management and operational experience Mr. Farah has obtained through over 40 years in the retail indtry enables him to provide insights, particularly in the areas of ctomer trends, product development, brand management, and risk analysis, from a consumer foced indtry that is different than the property and casualty insurance indtry. Due to his current and past service as a director of other public companies, he also has significant experience addressing the risks and corporate governance issues facing public companies, including serving as a member of their executive, compensation, governance, and corporate social responsibility committees.
Betsy Cohen

Betsy Cohen担任Kyivstar Group Ltd.董事会成员和提名委员会成员。她自2021年10月起担任Cohen Circle董事会主席、首席执行官兼总裁。她从2000年9月起担任Bancorp及其全资子公司Bancorp Bank的首席执行官,从2003年11月起担任Bancorp Bank的董事长,并于2014年12月退休后辞去这些职务。从1997年8月创立至2010年12月31日辞职,她一直担任房地产投资TRT RAIT Financial TRT的董事会主席和TRTE,并在1997年至2006年期间担任RAIT的首席执行官。Cohen女士于1999年12月至2000年7月期间担任JeffBanks,Inc.的继任者Hudson 联合合众银行(一家银行控股公司)的董事,并于1999年12月至2000年3月期间担任Hudson United Bank(Hudson United Bancorp 联合合众银行的银行子公司)Jefferson Bank Division的董事长。在JeffBanks,Inc.与Hudson 联合合众银行于1999年12月合并之前,Cohen女士自1981年成立以来一直担任JeffBanks,Inc.的董事长兼首席执行官,还曾担任该公司旗下每一家子公司的董事长兼首席执行官,这些子公司是她于1974年创立的Jefferson Bank和她于1987年创立的Jefferson Bank New Jersey。从1985年到1993年,Cohen女士担任First Union Corp. of Virginia(一家银行控股公司)及其前身Dominion Bancshares,Inc.的董事。1969年,Cohen女士创立了一家商业律师事务所,并担任高级合伙人至1984年。Cohen女士还于1994年至2018年5月期间担任保险公司Aetna,Inc.(NYSE:AET)的董事,并于2021年2月至2021年7月期间担任INSUII的继任者Metromile, Inc.的董事。


Betsy Cohen has served as a member of board of directors and Chief Executive Officer and President since December 2024. She served as Chairman of the board of directors of FTAC Emerald from April 2021 until its February 2025 biness combination with Fold Holdings, Inc. Ms. Cohen served as Chairman, President and Chief Executive Officer of Cohen Circle I from October 2021 until the consummation of its biness combination with Kyivstar Group Ltd., in Augt 2025, and has served as a director of Kyivstar Group Ltd. since then. She is currently Chairman of the board of directors of BTC Development, a managing member of the general partner of Cohen Circle FinTech Ventures, L.P., a fintech foced venture capital fund, since January 2023, and a managing member of the general partner of Radiate Capital Fund, L.P., an impact investment fund with a foc on the financial services and health sectors, since June 2024.Ms. Cohen served as a director of Hudson United Bancorp (a bank holding company), the successor to JeffBanks, Inc., from December 1999 until July 2000 and as the Chairman of the Jefferson Bank Division of Hudson United Bank (Hudson United Bancorp's banking subsidiary) from December 1999 through March 2000. Before the merger of JeffBanks, Inc. with Hudson United Bancorp in December 1999, Ms. Cohen was Chairman and Chief Executive Officer of JeffBanks, Inc. from its inception in 1981 and also served as Chairman and Chief Executive Officer of each of its subsidiaries, Jefferson Bank, which she founded in 1974, and Jefferson Bank New Jersey, which she founded in 1987. From 1985 until 1993, Ms. Cohen was a director of First Union Corp. of Virginia (a bank holding company) and its predecessor, Dominion Bancshares, Inc. In 1969, Ms. Cohen co founded a commercial law firm and served as a senior partner until 1984. Ms. Cohen also served as a director of Aetna, Inc. (NYSE: AET), an insurance company, from 1994 until May 2018 and as a director of Metromile, Inc., the successor to INSU II, from February 2021 until July 2021.
Betsy Cohen担任Kyivstar Group Ltd.董事会成员和提名委员会成员。她自2021年10月起担任Cohen Circle董事会主席、首席执行官兼总裁。她从2000年9月起担任Bancorp及其全资子公司Bancorp Bank的首席执行官,从2003年11月起担任Bancorp Bank的董事长,并于2014年12月退休后辞去这些职务。从1997年8月创立至2010年12月31日辞职,她一直担任房地产投资TRT RAIT Financial TRT的董事会主席和TRTE,并在1997年至2006年期间担任RAIT的首席执行官。Cohen女士于1999年12月至2000年7月期间担任JeffBanks,Inc.的继任者Hudson 联合合众银行(一家银行控股公司)的董事,并于1999年12月至2000年3月期间担任Hudson United Bank(Hudson United Bancorp 联合合众银行的银行子公司)Jefferson Bank Division的董事长。在JeffBanks,Inc.与Hudson 联合合众银行于1999年12月合并之前,Cohen女士自1981年成立以来一直担任JeffBanks,Inc.的董事长兼首席执行官,还曾担任该公司旗下每一家子公司的董事长兼首席执行官,这些子公司是她于1974年创立的Jefferson Bank和她于1987年创立的Jefferson Bank New Jersey。从1985年到1993年,Cohen女士担任First Union Corp. of Virginia(一家银行控股公司)及其前身Dominion Bancshares,Inc.的董事。1969年,Cohen女士创立了一家商业律师事务所,并担任高级合伙人至1984年。Cohen女士还于1994年至2018年5月期间担任保险公司Aetna,Inc.(NYSE:AET)的董事,并于2021年2月至2021年7月期间担任INSUII的继任者Metromile, Inc.的董事。
Betsy Cohen has served as a member of board of directors and Chief Executive Officer and President since December 2024. She served as Chairman of the board of directors of FTAC Emerald from April 2021 until its February 2025 biness combination with Fold Holdings, Inc. Ms. Cohen served as Chairman, President and Chief Executive Officer of Cohen Circle I from October 2021 until the consummation of its biness combination with Kyivstar Group Ltd., in Augt 2025, and has served as a director of Kyivstar Group Ltd. since then. She is currently Chairman of the board of directors of BTC Development, a managing member of the general partner of Cohen Circle FinTech Ventures, L.P., a fintech foced venture capital fund, since January 2023, and a managing member of the general partner of Radiate Capital Fund, L.P., an impact investment fund with a foc on the financial services and health sectors, since June 2024.Ms. Cohen served as a director of Hudson United Bancorp (a bank holding company), the successor to JeffBanks, Inc., from December 1999 until July 2000 and as the Chairman of the Jefferson Bank Division of Hudson United Bank (Hudson United Bancorp's banking subsidiary) from December 1999 through March 2000. Before the merger of JeffBanks, Inc. with Hudson United Bancorp in December 1999, Ms. Cohen was Chairman and Chief Executive Officer of JeffBanks, Inc. from its inception in 1981 and also served as Chairman and Chief Executive Officer of each of its subsidiaries, Jefferson Bank, which she founded in 1974, and Jefferson Bank New Jersey, which she founded in 1987. From 1985 until 1993, Ms. Cohen was a director of First Union Corp. of Virginia (a bank holding company) and its predecessor, Dominion Bancshares, Inc. In 1969, Ms. Cohen co founded a commercial law firm and served as a senior partner until 1984. Ms. Cohen also served as a director of Aetna, Inc. (NYSE: AET), an insurance company, from 1994 until May 2018 and as a director of Metromile, Inc., the successor to INSU II, from February 2021 until July 2021.
Frank M. Clark, Jr.

Frank M. Clark, Jr.于2012年2月从联邦爱迪生公司的董事长兼首席执行官职务上退休,联邦爱迪生公司“ComEd”( 爱克斯龙电力公司子公司),他于2005年开始担任这份职务。自2001年10月至2005年期间内他在联邦艾迪生公司担任总裁,自2004年至2005年期间内他在爱克斯龙电力公司董事会担任执行副总裁兼参谋长。他于1966年加入联邦爱迪生公司,并负责操作和政策相关的责任工作包括监管和政府事务、客户服务业务、营销和销售、信息技术、人力资源和劳动关系以及销售支持服务。他在加拿大蒙特利尔银行金融集团担任非执行董事长。


Frank M. Clark, Jr. is President of the Chicago Board of Education. Mr. Clark retired in February 2012 as the Chairman and Chief Executive Officer of Commonwealth Edison Company “ComEd” (an electric energy distribution subsidiary of Exelon Corporation), having served in this position since November 2005. Previously, Mr. Clark served as President of ComEd from October 2001 to 2005 and Executive Vice President and Chief of Staff to the Exelon Corporation Chairman from 2004 to 2005. After joining ComEd in 1966 Mr. Clark held key leadership positions in operational and policy-related responsibilities, including regulatory and governmental affairs, customer service operations, marketing and sales, information technology, human resources and labor relations, and distribution support services. Mr. Clark served as a director of BMO Financial Corporation (financial services) from May 2005 to December 2016 and its non-executive chairman from December 2010 to December 2016.
Frank M. Clark, Jr.于2012年2月从联邦爱迪生公司的董事长兼首席执行官职务上退休,联邦爱迪生公司“ComEd”( 爱克斯龙电力公司子公司),他于2005年开始担任这份职务。自2001年10月至2005年期间内他在联邦艾迪生公司担任总裁,自2004年至2005年期间内他在爱克斯龙电力公司董事会担任执行副总裁兼参谋长。他于1966年加入联邦爱迪生公司,并负责操作和政策相关的责任工作包括监管和政府事务、客户服务业务、营销和销售、信息技术、人力资源和劳动关系以及销售支持服务。他在加拿大蒙特利尔银行金融集团担任非执行董事长。
Frank M. Clark, Jr. is President of the Chicago Board of Education. Mr. Clark retired in February 2012 as the Chairman and Chief Executive Officer of Commonwealth Edison Company “ComEd” (an electric energy distribution subsidiary of Exelon Corporation), having served in this position since November 2005. Previously, Mr. Clark served as President of ComEd from October 2001 to 2005 and Executive Vice President and Chief of Staff to the Exelon Corporation Chairman from 2004 to 2005. After joining ComEd in 1966 Mr. Clark held key leadership positions in operational and policy-related responsibilities, including regulatory and governmental affairs, customer service operations, marketing and sales, information technology, human resources and labor relations, and distribution support services. Mr. Clark served as a director of BMO Financial Corporation (financial services) from May 2005 to December 2016 and its non-executive chairman from December 2010 to December 2016.
Olympia J. Snowe

Olympia J. Snowe, 自2013年6月成为普莱斯集团独立董事,现任执行薪酬委员会成员。她是奥林匹亚斯诺有限责任公司(一家政策和通信咨询公司)董事长和首席执行官以及两党政策中心高级研究员。她从1995年到2013年担任美国缅因州参议员;1979年到1995年担任众议院代表。在美国参议院任职期间,她担任小型企业参议委员会主席和高级成员;参议院财政委员会,参议院情报委员会和参议院商业科学技术委员会成员。她还担任参议院军事委员会海权小组委员会主席。她持有缅因大学理学学士学位以及多个大学和学院的荣誉学士学位。


Olympia J. Snowe has been a director since November 2015 and was a non-voting Board observer from January 2015 to November 2015. She has also been a member of the board of directors of the Bank since January 2017. She is currently Chairman and CEO of Olympia Snowe, LLC, a policy and communications consulting firm, and a senior fellow at the Bipartisan Policy Center, a non-profit organization focused on national policy solutions, where she is also a member of the board, and co-chairs its Commission on Political Reform. Senator Snowe currently serves on the board of directors of T. Rowe Price Group, Inc., a financial services company, and she previously served on the board of directors of Aetna, Inc., a diversified healthcare benefits company. Senator Snowe served in the U.S. Senate from 1995-2013 and as a member of the U.S. House of Representatives from 1979-1995. While in the U.S. Senate, she served as Chair and was the ranking member of the Senate Committee on Small Business and Entrepreneurship, and served on the Senate Finance Committee, the Senate Intelligence Committee, and the Senate Commerce Science and Technology Committee. She also served as Chair of the Subcommittee on Seapower for the Senate Armed Services Committee. Senator Snowe received recognition from the National Association of Corporate Directors as an NACD Directorship 100 "Class of 2015". Senator Snowe received a B.A. in political science from the University of Maine and has received honorary doctorate degrees from many colleges and universities.
Olympia J. Snowe, 自2013年6月成为普莱斯集团独立董事,现任执行薪酬委员会成员。她是奥林匹亚斯诺有限责任公司(一家政策和通信咨询公司)董事长和首席执行官以及两党政策中心高级研究员。她从1995年到2013年担任美国缅因州参议员;1979年到1995年担任众议院代表。在美国参议院任职期间,她担任小型企业参议委员会主席和高级成员;参议院财政委员会,参议院情报委员会和参议院商业科学技术委员会成员。她还担任参议院军事委员会海权小组委员会主席。她持有缅因大学理学学士学位以及多个大学和学院的荣誉学士学位。
Olympia J. Snowe has been a director since November 2015 and was a non-voting Board observer from January 2015 to November 2015. She has also been a member of the board of directors of the Bank since January 2017. She is currently Chairman and CEO of Olympia Snowe, LLC, a policy and communications consulting firm, and a senior fellow at the Bipartisan Policy Center, a non-profit organization focused on national policy solutions, where she is also a member of the board, and co-chairs its Commission on Political Reform. Senator Snowe currently serves on the board of directors of T. Rowe Price Group, Inc., a financial services company, and she previously served on the board of directors of Aetna, Inc., a diversified healthcare benefits company. Senator Snowe served in the U.S. Senate from 1995-2013 and as a member of the U.S. House of Representatives from 1979-1995. While in the U.S. Senate, she served as Chair and was the ranking member of the Senate Committee on Small Business and Entrepreneurship, and served on the Senate Finance Committee, the Senate Intelligence Committee, and the Senate Commerce Science and Technology Committee. She also served as Chair of the Subcommittee on Seapower for the Senate Armed Services Committee. Senator Snowe received recognition from the National Association of Corporate Directors as an NACD Directorship 100 "Class of 2015". Senator Snowe received a B.A. in political science from the University of Maine and has received honorary doctorate degrees from many colleges and universities.

高管简历

中英对照 |  中文 |  英文
Harold L. Paz

Harold L. Paz,于2014年7月28日成为执行副总裁和首席医疗官。加入Aetna之前,Paz博士曾担任Penn State Hershey Medical Center and Health System首席执行官,担任Health Affairs for Penn State University高级副总裁,担任该学校医学院院长以及从2006年4月起担任医学和公共卫生科学教授。


Harold L. Paz has served as a director of the Company since February 2017. Dr. Paz has served as the Executive Vice President and Chief Medical Officer of Aetna, Inc. which was acquired by CVS Health Corp. in 2018 since July 2014 and a Professor Adjunct of Internal Medicine at Yale University School of Medicine since 2015. From April 2006 to July 2014 Dr. Paz was the President and Chief Executive Officer of Penn State Hershey Health System and Medical Center, as well as the Senior Vice President for Health Affairs and Dean of the College of Medicine for The Pennsylvania State University. Prior to his appointment at Penn State, Dr. Paz served as the Dean and Chief Executive Officer of the Robert Wood Johnson Medical School and Robert Wood Johnson University Medical Group. Dr. Paz also serves on the board of directors for United Surgical Partners International, Inc. as well as several other private companies, foundations and other hospitals and healthcare systems.
Harold L. Paz,于2014年7月28日成为执行副总裁和首席医疗官。加入Aetna之前,Paz博士曾担任Penn State Hershey Medical Center and Health System首席执行官,担任Health Affairs for Penn State University高级副总裁,担任该学校医学院院长以及从2006年4月起担任医学和公共卫生科学教授。
Harold L. Paz has served as a director of the Company since February 2017. Dr. Paz has served as the Executive Vice President and Chief Medical Officer of Aetna, Inc. which was acquired by CVS Health Corp. in 2018 since July 2014 and a Professor Adjunct of Internal Medicine at Yale University School of Medicine since 2015. From April 2006 to July 2014 Dr. Paz was the President and Chief Executive Officer of Penn State Hershey Health System and Medical Center, as well as the Senior Vice President for Health Affairs and Dean of the College of Medicine for The Pennsylvania State University. Prior to his appointment at Penn State, Dr. Paz served as the Dean and Chief Executive Officer of the Robert Wood Johnson Medical School and Robert Wood Johnson University Medical Group. Dr. Paz also serves on the board of directors for United Surgical Partners International, Inc. as well as several other private companies, foundations and other hospitals and healthcare systems.
Karen S. Lynch

Karen S. Lynch是一位经验丰富的医疗保健高管,在该行业拥有超过30年的经验。她曾担任CVS Health Corporation (NYSE: CVS)(“CVS Health”)(一家领先的健康解决方案公司)的前总裁兼首席执行官,负责领导超过30万名员工。Lynch女士的领导下,CVS健康感动的生活超过1.2亿消费者通过其卫生保健福利和药房福利管理业务,并在9000多个社区卫生的目的地在美国之前,她服务的总裁兼首席执行官CVS健康,林奇女士担任执行副总裁CVS安泰健康和总裁,在此之前,林奇女士担任安泰公司的一些高管,健康保险公司麦哲伦健康服务公司(一家医疗保健管理公司)和信诺公司(一家全球健康保险公司)。她的职业生涯始于审计公司Ernst & Young LLP的注册会计师,此前曾担任CVS Health和U.S. Bancorp的董事会成员。


Karen S. Lynch,is a seasoned health care executive who has over three decades of experience in the industry. As the former president and chief executive officer of CVS Health Corporation (NYSE: CVS) ("CVS Health"), a leading health solutions company, where she was responsible for leading more than 300,000 employees. Under Ms. Lynch's leadership, CVS Health touched the lives of more than 120 million consumers through its health care benefits and pharmacy benefits management businesses, and presence in over 9,000 community health destinations across the U.S. Prior to her service as president and CEO of CVS Health, Ms. Lynch served as an Executive Vice President of CVS Health and President of Aetna, and prior to that, Ms. Lynch held a number of executive positions at Aetna Inc., a health insurance company, Magellan Health Services, a health care management company, and at Cigna Corporation, a global health insurance company. Ms. Lynch began her career as a Certified Public Accountant at the auditing firm Ernst & Young LLP, and has previously served as a board member of CVS Health and U.S. Bancorp.
Karen S. Lynch是一位经验丰富的医疗保健高管,在该行业拥有超过30年的经验。她曾担任CVS Health Corporation (NYSE: CVS)(“CVS Health”)(一家领先的健康解决方案公司)的前总裁兼首席执行官,负责领导超过30万名员工。Lynch女士的领导下,CVS健康感动的生活超过1.2亿消费者通过其卫生保健福利和药房福利管理业务,并在9000多个社区卫生的目的地在美国之前,她服务的总裁兼首席执行官CVS健康,林奇女士担任执行副总裁CVS安泰健康和总裁,在此之前,林奇女士担任安泰公司的一些高管,健康保险公司麦哲伦健康服务公司(一家医疗保健管理公司)和信诺公司(一家全球健康保险公司)。她的职业生涯始于审计公司Ernst & Young LLP的注册会计师,此前曾担任CVS Health和U.S. Bancorp的董事会成员。
Karen S. Lynch,is a seasoned health care executive who has over three decades of experience in the industry. As the former president and chief executive officer of CVS Health Corporation (NYSE: CVS) ("CVS Health"), a leading health solutions company, where she was responsible for leading more than 300,000 employees. Under Ms. Lynch's leadership, CVS Health touched the lives of more than 120 million consumers through its health care benefits and pharmacy benefits management businesses, and presence in over 9,000 community health destinations across the U.S. Prior to her service as president and CEO of CVS Health, Ms. Lynch served as an Executive Vice President of CVS Health and President of Aetna, and prior to that, Ms. Lynch held a number of executive positions at Aetna Inc., a health insurance company, Magellan Health Services, a health care management company, and at Cigna Corporation, a global health insurance company. Ms. Lynch began her career as a Certified Public Accountant at the auditing firm Ernst & Young LLP, and has previously served as a board member of CVS Health and U.S. Bancorp.
Richard M. Jelinek

RichardM.Jelinek于2017年3月成为Enterprise Strategy执行Vice President,自2015年11月2日起担任Humana Integration执行Vice President。加入Aetna之前,他曾担任Advent International公司的运营合伙人(2013年9月以来)。在此之前,Jelinek先生于1994年至2013年在UnitedHealth Group及其附属公司担任过一系列高级领导职务,包括UnitedHealth Group的执行Vice President和OptumHealth的首席执行官。


Richard M. Jelinek became Executive Vice President, Enterprise Strategy in March 2017 having served as Executive Vice President, Humana Integration since November 2 2015. Prior to joining Aetna, Mr. Jelinek served as an operating partner at Advent International, a position he assumed in September 2013. Prior to that, Mr. Jelinek held a series of senior leadership positions at UnitedHealth Group and its affiliates from 1994-2013 including Executive Vice President of UnitedHealth Group and CEO of OptumHealth.
RichardM.Jelinek于2017年3月成为Enterprise Strategy执行Vice President,自2015年11月2日起担任Humana Integration执行Vice President。加入Aetna之前,他曾担任Advent International公司的运营合伙人(2013年9月以来)。在此之前,Jelinek先生于1994年至2013年在UnitedHealth Group及其附属公司担任过一系列高级领导职务,包括UnitedHealth Group的执行Vice President和OptumHealth的首席执行官。
Richard M. Jelinek became Executive Vice President, Enterprise Strategy in March 2017 having served as Executive Vice President, Humana Integration since November 2 2015. Prior to joining Aetna, Mr. Jelinek served as an operating partner at Advent International, a position he assumed in September 2013. Prior to that, Mr. Jelinek held a series of senior leadership positions at UnitedHealth Group and its affiliates from 1994-2013 including Executive Vice President of UnitedHealth Group and CEO of OptumHealth.
Margaret M. McCarthy

Margaret M. McCarthy,退休的CVS Health Corporation(一家总部位于美国的医疗保健公司)的技术集成执行副总裁(2018年12月至2019年6月)。Aetna, Inc.(多元化的医疗保健福利公司)的运营和技术执行副总裁(2010 - 2018)。在2003年加入Aetna之前,她曾在CIGNA Healthcare和Catholic Health initiatives担任信息技术相关职位。McCarthy在Aetna负责创新、技术、数据安全、采购、房地产和服务运营。她还曾在埃森哲(Accenture)从事技术咨询工作,并担任安永(Ernst & Young)的咨询合伙人。她之前是一家数据中心和云安全公司的董事。她在受监管的保险行业、业务战略、客户体验以及网络和物理安全方面拥有丰富的经验。


Margaret M. McCarthy Retired executive vice president Technology Integration of CVS Health Corporation, a U.S. based healthcare company (2018 2019). Executive vice president of operations and technology for Aetna, Inc., a diversified health care benefits company (2010 2018). Prior to joining Aetna in 2003, she served in information technology related roles at CIGNA Healthcare and Catholic Health Initiatives.
Margaret M. McCarthy,退休的CVS Health Corporation(一家总部位于美国的医疗保健公司)的技术集成执行副总裁(2018年12月至2019年6月)。Aetna, Inc.(多元化的医疗保健福利公司)的运营和技术执行副总裁(2010 - 2018)。在2003年加入Aetna之前,她曾在CIGNA Healthcare和Catholic Health initiatives担任信息技术相关职位。McCarthy在Aetna负责创新、技术、数据安全、采购、房地产和服务运营。她还曾在埃森哲(Accenture)从事技术咨询工作,并担任安永(Ernst & Young)的咨询合伙人。她之前是一家数据中心和云安全公司的董事。她在受监管的保险行业、业务战略、客户体验以及网络和物理安全方面拥有丰富的经验。
Margaret M. McCarthy Retired executive vice president Technology Integration of CVS Health Corporation, a U.S. based healthcare company (2018 2019). Executive vice president of operations and technology for Aetna, Inc., a diversified health care benefits company (2010 2018). Prior to joining Aetna in 2003, she served in information technology related roles at CIGNA Healthcare and Catholic Health Initiatives.
Mark T. Bertolini

Mark T. Bertolini在安泰保险公司担任董事会主席、首席执行官兼总裁。他于2011年4月8日担任董事会主席职务,于2010年11月29日担任首席执行官职务。他于2003年加入安泰保险公司并成为安泰专业产品制造负责人。他于2007年7月被任命为总裁,并负责处理涵盖安泰企业业务范围的广泛医疗保健产品和相关服务的事务。在成为安泰公司的总裁之前,他担任执行副总裁兼管理人,负责安泰公司的地区业务,其中包括公司的在职人员、退休人员、项目小组和中间市场业务,还包括众多产品、网络和服务区域业务。在加入安泰公司之前,他在信诺保险集团、NYLCare健康计划公司与SelectCare公司担任首席职位,他在这些公司担任总裁兼首席执行官,他还在墙洞帮儿童营和Fidelco导盲犬协会担任董事,墙洞帮儿童营是一个由保罗-纽曼创办的组织,这个组织专门帮助患有癌症或其他严重疾病的儿童。Fidelco导盲犬协会是一个繁殖,训练和接收德国牧羊犬导盲犬以帮助失明人士的组织。


Mark T. Bertolini,currently serving as the Chief Executive Officer of Oscar Health, Inc., a health insurance company that leverages a full-stack technology platform, a position he has held since 2023.Before taking on the role at Oscar Health, Mark was the Co-Chief Executive Officer of Bridgewater Associates, LP, a prominent global investment management firm, from 2022 to 2023. His extensive career in the healthcare industry includes significant leadership roles at Aetna Inc., a Fortune 100 diversified healthcare benefits company, where he served as Chairman from 2011 to 2018, Chief Executive Officer from 2010 to 2018, and President from 2007 to 2010. Prior to these roles, he held various executive positions at Aetna from 2003 to 2007.Mark's career began in the healthcare sector, where he held executive positions at companies such as Cigna, NYLCare Health Plans, and SelectCare, Inc. from 1985 to 2003.
Mark T. Bertolini在安泰保险公司担任董事会主席、首席执行官兼总裁。他于2011年4月8日担任董事会主席职务,于2010年11月29日担任首席执行官职务。他于2003年加入安泰保险公司并成为安泰专业产品制造负责人。他于2007年7月被任命为总裁,并负责处理涵盖安泰企业业务范围的广泛医疗保健产品和相关服务的事务。在成为安泰公司的总裁之前,他担任执行副总裁兼管理人,负责安泰公司的地区业务,其中包括公司的在职人员、退休人员、项目小组和中间市场业务,还包括众多产品、网络和服务区域业务。在加入安泰公司之前,他在信诺保险集团、NYLCare健康计划公司与SelectCare公司担任首席职位,他在这些公司担任总裁兼首席执行官,他还在墙洞帮儿童营和Fidelco导盲犬协会担任董事,墙洞帮儿童营是一个由保罗-纽曼创办的组织,这个组织专门帮助患有癌症或其他严重疾病的儿童。Fidelco导盲犬协会是一个繁殖,训练和接收德国牧羊犬导盲犬以帮助失明人士的组织。
Mark T. Bertolini,currently serving as the Chief Executive Officer of Oscar Health, Inc., a health insurance company that leverages a full-stack technology platform, a position he has held since 2023.Before taking on the role at Oscar Health, Mark was the Co-Chief Executive Officer of Bridgewater Associates, LP, a prominent global investment management firm, from 2022 to 2023. His extensive career in the healthcare industry includes significant leadership roles at Aetna Inc., a Fortune 100 diversified healthcare benefits company, where he served as Chairman from 2011 to 2018, Chief Executive Officer from 2010 to 2018, and President from 2007 to 2010. Prior to these roles, he held various executive positions at Aetna from 2003 to 2007.Mark's career began in the healthcare sector, where he held executive positions at companies such as Cigna, NYLCare Health Plans, and SelectCare, Inc. from 1985 to 2003.
Thomas J. Sabatino, Jr.

Thomas J. Sabatino, Jr.,2011年9月开始担任执行副总裁、法律总顾问兼公司秘书。2010年3月至2010年12月,他担任美国联合航空公司执行副总裁兼法律总顾问。2004年4月至2009年11月,他担任先灵葆雅公司执行副总裁兼法律总顾问。2011年11月开始他担任Unigene Laboratories董事,Unigene Laboratories是一家生物制药公司,专注于医用微蛋白质。2012年4月,他任联合博姿公司董事。


Thomas J. Sabatino, Jr. joined Tenneco as Executive Vice President, General Counsel and Corporate Secretary in February 2021. Prior to joining Tenneco, Mr. Sabatino served as the executive vice president and general counsel of Aetna from April 2016 to December 2018. Prior to joining Aetna, Mr. Sabatino served as senior executive vice president, chief administrative officer and general counsel of Hertz Global Holdings, Inc. from February 2015 through April 2016 and executive vice president, global legal and chief administrative officer of Walgreens Boots Alliance from September 2011 through January 2015.
Thomas J. Sabatino, Jr.,2011年9月开始担任执行副总裁、法律总顾问兼公司秘书。2010年3月至2010年12月,他担任美国联合航空公司执行副总裁兼法律总顾问。2004年4月至2009年11月,他担任先灵葆雅公司执行副总裁兼法律总顾问。2011年11月开始他担任Unigene Laboratories董事,Unigene Laboratories是一家生物制药公司,专注于医用微蛋白质。2012年4月,他任联合博姿公司董事。
Thomas J. Sabatino, Jr. joined Tenneco as Executive Vice President, General Counsel and Corporate Secretary in February 2021. Prior to joining Tenneco, Mr. Sabatino served as the executive vice president and general counsel of Aetna from April 2016 to December 2018. Prior to joining Aetna, Mr. Sabatino served as senior executive vice president, chief administrative officer and general counsel of Hertz Global Holdings, Inc. from February 2015 through April 2016 and executive vice president, global legal and chief administrative officer of Walgreens Boots Alliance from September 2011 through January 2015.
Margaret M. McCarthy

Margaret M. McCarthy于2010年11月29日开始担任执行副总裁并负责操作和技术工作。她于2010年1月1日开始担任首席信息官兼高级副总裁,并负责技术服务操作工作。自2008年1月30日至2009年12月31日她开始担任首席信息官、采购与不动产高级副总裁。


Margaret M. McCarthy became Executive Vice President, Operations and Technology on November 29 2010 having served as Chief Information Officer since June 3 2005 and Senior Vice President Innovation, Technology and Service Operations since January 1 2010.
Margaret M. McCarthy于2010年11月29日开始担任执行副总裁并负责操作和技术工作。她于2010年1月1日开始担任首席信息官兼高级副总裁,并负责技术服务操作工作。自2008年1月30日至2009年12月31日她开始担任首席信息官、采购与不动产高级副总裁。
Margaret M. McCarthy became Executive Vice President, Operations and Technology on November 29 2010 having served as Chief Information Officer since June 3 2005 and Senior Vice President Innovation, Technology and Service Operations since January 1 2010.
Francis S. Soistman

Francis S. Soistman于2013年6月14日担任执行副总裁,负责政府服务业务。他于2013年5月20日开始担任联邦医疗保险总裁职务,他于2013年1月14日开始担任医疗保险主管职务。在加入美国人寿保险公司之前,他于2010年在茉莉医疗公司担任执行副总裁职务。在此之前,他在考文垂担任执行副总裁,并负责个人消费和政府业务部门的工作。


Francis S. Soistman,has served as Ehealth, Inc. Chief Executive Officer and member of Ehealth, Inc. Board of Directors since November 2021. Mr. Soistman founded and previously served as president of Healthcare Management and Transformation Advisory Services LLC, an advisory services company operating in the healthcare space, from January 2020 to November 2021. From January 2013 to September 2019, Mr. Soistman was executive vice president at CVS Health, a health solutions company, and president of government services at Aetna, a managed care company. Prior to his tenure at Aetna, Mr. Soistman co-founded Jessamine Healthcare, having previously served in executive leadership across a number of health care and managed care companies, including Coventry Healthcare, Principal Health Care and Blue Cross Blue Shield of Maryland. Mr. Soistman holds a B.S. in accounting and finance from Towson University and is a graduate of the Stanford University executive program.
Francis S. Soistman于2013年6月14日担任执行副总裁,负责政府服务业务。他于2013年5月20日开始担任联邦医疗保险总裁职务,他于2013年1月14日开始担任医疗保险主管职务。在加入美国人寿保险公司之前,他于2010年在茉莉医疗公司担任执行副总裁职务。在此之前,他在考文垂担任执行副总裁,并负责个人消费和政府业务部门的工作。
Francis S. Soistman,has served as Ehealth, Inc. Chief Executive Officer and member of Ehealth, Inc. Board of Directors since November 2021. Mr. Soistman founded and previously served as president of Healthcare Management and Transformation Advisory Services LLC, an advisory services company operating in the healthcare space, from January 2020 to November 2021. From January 2013 to September 2019, Mr. Soistman was executive vice president at CVS Health, a health solutions company, and president of government services at Aetna, a managed care company. Prior to his tenure at Aetna, Mr. Soistman co-founded Jessamine Healthcare, having previously served in executive leadership across a number of health care and managed care companies, including Coventry Healthcare, Principal Health Care and Blue Cross Blue Shield of Maryland. Mr. Soistman holds a B.S. in accounting and finance from Towson University and is a graduate of the Stanford University executive program.
Shawn M. Guertin

Shawn M. Guertin于2014年2月2日成为执行副总裁、财务总监以及企业风险总监,他于2013年2月25日开始担任高级副总裁、财务总监以及企业风险总监。在此之前,他于2011年4月开始担任业务部门负责人。再加入安泰保险公司之前,自2010年1月1日至2010年12月31日期间内他于考文垂担任顾问。自2005年3月至2009年11月期间内他开始担任考文垂的执行副总裁,财务总监以及财务主管。


Shawn M. Guertin,Executive Vice President and Chief Financial Officer of CVS Health Corporation since May 2021; Executive Vice President, Chief Financial Officer and Chief Enterprise Risk Officer of Aetna Inc. from February 2013 through May 2019; Senior Vice President, Finance of Aetna Inc. from April 2011 through January 2013.
Shawn M. Guertin于2014年2月2日成为执行副总裁、财务总监以及企业风险总监,他于2013年2月25日开始担任高级副总裁、财务总监以及企业风险总监。在此之前,他于2011年4月开始担任业务部门负责人。再加入安泰保险公司之前,自2010年1月1日至2010年12月31日期间内他于考文垂担任顾问。自2005年3月至2009年11月期间内他开始担任考文垂的执行副总裁,财务总监以及财务主管。
Shawn M. Guertin,Executive Vice President and Chief Financial Officer of CVS Health Corporation since May 2021; Executive Vice President, Chief Financial Officer and Chief Enterprise Risk Officer of Aetna Inc. from February 2013 through May 2019; Senior Vice President, Finance of Aetna Inc. from April 2011 through January 2013.